Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-77P stands for "RNA, U1 small nuclear 77, pseudogene," a member of the large U1 small nuclear RNA pseudogene family in humans[1][3]. Unlike functional U1 RNAs, which are critical non-coding RNAs responsible for 5′ splice site recognition during pre-mRNA splicing, RNU1-77P is annotated as a pseudogene and is not believed to produce a functional product[1][3]. Pseudogenes such as RNU1-77P may be the remnants of gene duplications or retrotransposition events; most are not transcribed or, if transcribed, do not play an established biological function[3]. There is no evidence that RNU1-77P acts as a therapeutic or diagnostic target, nor does it have a role in disease, drug interactions, or biomarker relevance in current biomedical databases. It is not a functional receptor, enzyme, transporter, or other canonical drug target class.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 77, pseudogene (RNU1-77P).